# Armata Pharmaceuticals, Inc.: insider transactions

ARMP · NYSE · CIK 921114 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/armp.md) · [Financials](/companies/armp/financials.md) · [Filings](/companies/armp/filings.md) · [Insiders](/companies/armp/insiders.md)

## All transactions: 6

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2022-03-31 | [Innoviva, Inc.](/insiders/1080014.md) | Director, 10% owner | Purchase (P) | 5,385,208 | $5.00 | $26.9m | [Form 4](/filings/0001567619-22-007861.md) |
| 2022-02-09 | [Innoviva, Inc.](/insiders/1080014.md) | Director, 10% owner | Purchase (P) | 3,614,792 | $5.00 | $18.1m | [Form 4](/filings/0001567619-22-003750.md) |
| 2021-10-29 | [Innoviva, Inc.](/insiders/1080014.md) | Director, 10% owner | Purchase (P) | 1,212,122 | $3.30 | $4.0m | [Form 4](/filings/0001567619-21-019063.md) |
| 2021-03-17 | [Innoviva, Inc.](/insiders/1080014.md) | Director, 10% owner | Purchase (P) | 4,285,935 | $3.25 | $13.9m | [Form 4](/filings/0001567619-21-006518.md) |
| 2021-01-26 | [Innoviva, Inc.](/insiders/1080014.md) | Director, 10% owner | Purchase (P) | 1,867,912 | $3.25 | $6.1m | [Form 4](/filings/0000899243-21-003595.md) |
| 2020-03-27 | [Innoviva, Inc.](/insiders/1080014.md) | 10% owner | Purchase (P) | 7,717,661 | $2.87 | $22.1m | [Form 4](/filings/0001567619-20-007226.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.